Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Pilot Randomized Control Trial Investigating Tai-chi/Qigong for Older Adults with Bipolar Disorder
FY 2018-19
Summary
It is expected that by 2030, the percentage of patients with bipolar disorder (BD) over 60 years of age will exceed 50% of all patients with BD. Despite this, there is a lack of research specific to older adults (age 60+) with bipolar disorder (OABD). In this population, poor cognition and persistent sub-syndromal depressive symptoms are particularly common, difficult to treat, associated with mood relapse, and poor daily functioning. As there are no current evidence-based treatments for cognition in OABD and current pharmacotherapies are limited, not effective in cognition, and often poorly-tolerated, there an urgent need to find alternative interventions for OABD. Mind-body interventions has increasingly been found to be effective in treating several psychiatric condition including BD. A few pilot studies examining mindfulness-based intervention in younger adult BD have been promising for depressive symptoms, but some pilot research by our team suggest that patients with OABD may benefit more from moving mindfulness, which is more accessible, requires less baseline cognitive abilities and allow easier engagement with mindfulness. Our study is a 12-week pilot randomized control trial (RCT) comparing 1h/week sessions of Tai-chi/Qigong (treatment) vs. light exercise (active control) in 30 OABD patients (age ? 50) to assess whether Tai-chi-Qigong, a form of moving mindfulness, is effective in 1) improving depressive symptoms, 2) preventing mood relapse, and 3) improving cognition in OABD. Pariticipants will be measured for depression and cognition at 0 weeks (baseline), 12 weeks (primary endpoint), and 24 weeks (long-term assessment), and results will be compared between the treatment and active control groups.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
406502
Name
Park Haley
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Pilot Randomized Control Trial Investigating Tai-chi/Qigong for Older Adults with Bipolar Disorder
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Mind-Body Intervention; Mindfulness; Older Adult Bipolar Disorder; Pilot Rct; Tai-Chi/Qigong
Abstract
It is expected that by 2030, the percentage of patients with bipolar disorder (BD) over 60 years of age will exceed 50% of all patients with BD. Despite this, there is a lack of research specific to older adults (age 60+) with bipolar disorder (OABD). In this population, poor cognition and persistent sub-syndromal depressive symptoms are particularly common, difficult to treat, associated with mood relapse, and poor daily functioning. As there are no current evidence-based treatments for cognition in OABD and current pharmacotherapies are limited, not effective in cognition, and often poorly-tolerated, there an urgent need to find alternative interventions for OABD. Mind-body interventions has increasingly been found to be effective in treating several psychiatric condition including BD. A few pilot studies examining mindfulness-based intervention in younger adult BD have been promising for depressive symptoms, but some pilot research by our team suggest that patients with OABD may benefit more from moving mindfulness, which is more accessible, requires less baseline cognitive abilities and allow easier engagement with mindfulness. Our study is a 12-week pilot randomized control trial (RCT) comparing 1h/week sessions of Tai-chi/Qigong (treatment) vs. light exercise (active control) in 30 OABD patients (age ? 50) to assess whether Tai-chi-Qigong, a form of moving mindfulness, is effective in 1) improving depressive symptoms, 2) preventing mood relapse, and 3) improving cognition in OABD. Pariticipants will be measured for depression and cognition at 0 weeks (baseline), 12 weeks (primary endpoint), and 24 weeks (long-term assessment), and results will be compared between the treatment and active control groups.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Park, Haley
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~